Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 25, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - February 25, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 71     Next >>     Go To Page:

2/17/17 - Patent Issued for Pharmaceutical Compositions Comprising Plant Extracts and Methods for Reducing Duration of a Common Cold Using Same (USPTO 9555069)
By a News Reporter-Staff News Editor at Drug Week A patent by the inventors Clarot, Timothy L.; Ascarate, Arlene M., filed on April 29, 2015, was published online on January 31, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9555069 is assigned to MATRIXX INITIATIVES, INC.. The com
2/17/17 - Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution
Perrigo Company plc today announced it has received final approval from the U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution, 5 mg/1. 5 mg per 5 mL. Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, offers patients and customers high quality p
2/17/17 - Research on Global OTC Drug Industry 2017 Market Sales, Consumer Demands, Drug Types, Medical Solutions & Threats: BioGaia, Cipla, Sanofi
The report provides its projected market size in terms of US$ mn for each leading regional segment.Brooklyn, NY 02/17/2017 The report on the global OTC Drug market has been compiled to serve as a valuable source of guidance for all companies wanting to make informed decisions for growth in OTC Drug Industry and also presents a figurative esti
2/16/17 - Capillus Laser Therapy Caps Receive FDA Clearance For Over-The-Counter Use
Capillus , LLC, a medical device manufacturer focused on providing customers with the best products in treatment for hair loss, announced today that the U.S. Food and Drug Administration has cleared its at-home laser therapy caps for over-the-counter treatment of hair loss, as well as its clinical-use standing laser unit, making it the only such
2/16/17 - Global Orthopaedic Imaging Market to be Valued at US$ 12.4 Billion During 2016-2026
Medical organisations and research institutes will continue to put more efforts towards development of advanced imaging devices. "The global market for orthopaedic imaging, which is currently valued at US$ 7.6 billion, will soar steadily at 4.9% CAGR to reach US$ 12.4 billion valuation by 2026." Request for Sample Report with Table of Contents:...
2/16/17 - Public Citizen: DeLauro Proposal Would Close Dangerous Gap in FDA Regulatory Authority
Rosa DeLauro for introducing commonsense legislation that would finally give the FDA the authority to order recalls of potentially tainted medications that pose an unacceptable health risk to patients. "Most people would be shocked to learn that while the FDA has the authority to order a recall of medical devices and biologic products, such as vac
2/15/17 - Acura Pharmaceuticals Common Stock To Trade On The OTCQB Market
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that shares of its common stock will begin to trade on the OTCQB Market, which is operated by OTC Markets Group Inc., under the symbol ACUR on February 23, 2017.. On August 16, 2016 the Company received a written notification
2/15/17 - Benzer Pharmacy Opens First Location in Colorado and Texas Through its Franchise Model [Sudan Tribune]
-Benzer Pharmacy, the nations fastest growing pharmacy has made an entrance in Colorado and Texas as a result of the Benzer Franchise model that was launched early last year. The Colorado pharmacy is located at 568 US HWY 36 Byers, Colorado 80103. Conveniently located inside Byers General Store, Benzer Pharmacy, previously known as Chase Pharmacy i
2/15/17 - ITL Pharma Receives United States Patent Protection for TriThroid Using Sustained Drug Release and Improved Product Stability [Tehran Times (Iran)]
-ITL Pharma, Inc., a LIAS Research Company, today announced awarding of a United States Patent titled: "Sustained Drug Release and Improved Product Stability Using Non-Covalent Particle Coating Methods." Keith R. Latham, ITL`s Chief Executive Officer. About ITL PharmaITL Pharma, Inc. is a privately held US Pharmaceutical company headquartered in Ki
2/15/17 - Nutra Pharma and Nyloxin Featured on NBC News-Miami
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, announced today that the Company and their products were featured in an interview aired last night on Miami s NBC News affiliate. NBC News has been featuring the use of natural products for the treatment
2/15/17 - QuintilesIMS posts mixed results, ups stock buyback plan [The News & Observer (Raleigh, N.C.)]
Shares of the company, which has headquarters in Danbury, Conn. and Durham, closed 3 percent higher Tuesday. Revenue for the quarter totaled $1.95 billion, a tad short of the $1.97 billion anticipated by Wall Street analysts polled by Bloomberg News. Durham- based Quintiles, a contract research organization that helps pharmaceutical companies condu
2/14/17 - Antibiotic future uncertain for livestock industry
As I write this, we are just a few short days into the veterinary feed directive coming into effect. This will be a year of adjustments and education for veterinarians, producers and the FDA. The latest FDA report on antibiotic sales shows that the trend continues to go up, not down.
2/14/17 - ITL Pharma Receives United States Patent Protection for TriThroid Using Sustained Drug Release and Improved Product Stability
ITL Pharma, Inc., a LIAS Research Company, today announced awarding of a United States Patent titled: "Sustained Drug Release and Improved Product Stability Using Non-Covalent Particle Coating Methods." Keith R. Latham, ITL's Chief Executive Officer. About ITL Pharma ITL Pharma, Inc. is a privately held US Pharmaceutical company headquartered in
2/14/17 - Vifor Pharma and ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases
Vifor Pharma, a company of the Galenica Group, and ChemoCentryx, Inc.,, announced today that Vifor Pharma has gained rights to commercialize avacopan in Asia, including Japan and the Middle-East. ChemoCentryx retains all rights in the United States and China. ChemoCentryx will receive an upfront cash commitment of USD 20 million in return for the
2/13/17 - Aralez To Ring Closing Bell At Nasdaq On February 14, 2017
Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, today announced the Company will ring the Nasdaq Closing Bell at the Nasdaq MarketSite in Times Square, New York at 4:00 p.m. ET on Tuesday, February 14, 2017 to celebrate its commitment to cardiovascular disease and the commercial launch of Yosprala . Chief Executive Offic
2/13/17 - Cheaper over-the-counter hearing aids could be on the way
Technology is already moving in this direction, and consumer marketers such as Samsung, Bose Corporation and Panasonic Corporation are reportedly readying new products of this kind. The devices "will be widely used by older people," just as earbuds are used by younger people today, predicted Richard Einhorn, a well-known composer who serves on the
2/13/17 - Pharmacies diversify to survive
Model Pharmacy isn t much of drug store any more. And when a sprawling Walgreens opened across the street, it was hard to compete with the buying power of large chains that not only fill prescriptions at lower prices, but also generate most of their income selling cigarettes, liquor and grocery staples like bread and milk. So independents in Alb
2/13/17 - Purdue Pharma and Commonwealth of Virginia Partner to Improve Utilization of Prescription Monitoring Program
By a News Reporter-Staff News Editor at Pharma Business Week Purdue Pharma L.P., Virginia Governor Terry McAuliffe and the Virginia Secretary of Health and Human Resources announced the formation of a private-public partnership to enhance utilization of the state prescription monitoring program as part of the solution to address the opioid crisis
2/13/17 - Relypsa Announces Publication of Results of Veltassa Drug-Drug Interaction Studies in Journal of Cardiovascular Pharmacology and Therapeutics
Relypsa, Inc., a Vifor Pharma company, today announced that results of drug-drug interaction studies of Veltassa for oral suspension were published online by the Journal of Cardiovascular Pharmacology and Therapeutics. Results from 12 individual Phase 1 studies in healthy volunteers of 12 oral medications showed there were no clinically meanin
2/13/17 - Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use in the United States
By a News Reporter-Staff News Editor at Pharma Business Week HYPERLINK " http://www.sanofi.com/"\ nSanofi announced that the U.S. Food and Drug Administration approved Xyzal Allergy 24 HR as an over-the-counter treatment for the relief of symptoms associated with seasonal and year-round allergies. "The FDA approval of Xyzal builds on our heri
2/13/17 - Statement from the Consumer Healthcare Productions Association (CHPA) Regarding Confirmation of HHS Secretary Price
Tom Price on his recent confirmation as Secretary of the U.S. Department of Health& Human Services. 'Given Secretary Price's oversight of FDA and its critical mission to protect and advance public health, we encourage him to consider the following qualities that CHPA feels are necessary for an ideal new FDA Commissioner: an ability to deal with com
2/12/17 - Pushing for gains vs. loss Changes in offing may aid hearing-impaired
Technology is already moving in this direction, and companies such as Samsung, Bose and Panasonic are reportedly readying new products of this kind. The devices "will be widely used by older people," just as ear buds are used by younger people today, predicted Richard Einhorn, a well-known composer who serves on the board of the Hearing Loss Associ
2/10/17 - Mission Pharmacal Market 2017 Share, Trend, Segmentation and Forecast to 2020
PUNE, INDIA, February 10, 2017/ EINPresswire.com/ Mission Pharmacal Company- Strategic SWOT Analysis Review provides a comprehensive insight into the company s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company s key employees, key competitors and major pr
2/9/17 - Appeals Court Grants Stay of Permanent Injunction for Praluent (alirocumab) During Appeals ProcessPraluent continues to be available to patients in the U.S. -
Release date- 08022017- Paris, France and Tarrytown, New York- Regeneron Pharmaceuticals, Inc and Sanofi announced today that the United States Court of Appeals for the Federal Circuit has stayed the permanent injunction for Praluent Injection pending the companies' appeal. This ruling means that Sanofi and Regeneron will continue marketing, sellin
2/9/17 - Brazilian Pharmaceutical Market Outlook 2016-2026
Revenue Forecasting of Originator, Generic and OTC Medicines and Therapy Areas Including CNS, Cardiovascular and Cancer; Exploration of Regional Differences in Healthcare; Discussion of Domestic Manufacturers Including EMS, Hypermarcas and Ach, and International Drug Companies Including Sanofi, Novartis and Roche Report Details Medicine Sales i
Articles(s): 1 - 25 of 71     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415